Design of a partial PPARδ agonist

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

Structure based ligand design was used in order to design a partial agonist for the PPARdelta receptor. The maximum activation in the transactivation assay was reduced from 87% to 39%. The crystal structure of the ligand binding domain of the PPARdelta receptor in complex with compound 2 was determined in order to understand the structural changes which gave rise to the decrease in maximum activation.

Knowledge Graph

Similar Paper

Design of a partial PPARδ agonist
Bioorganic & Medicinal Chemistry Letters 2007.0
Insights into the Mechanism of Partial Agonism
Journal of Biological Chemistry 2007.0
Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design
Journal of Medicinal Chemistry 2008.0
Design of potent PPARα agonists
Bioorganic & Medicinal Chemistry Letters 2007.0
Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method
Bioorganic & Medicinal Chemistry Letters 2022.0
Design, Synthesis, and Structural Analysis of Phenylpropanoic Acid-Type PPARγ-Selective Agonists: Discovery of Reversed Stereochemistry−Activity Relationship
Journal of Medicinal Chemistry 2011.0
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Structure-based identification of novel PPAR gamma ligands
Bioorganic & Medicinal Chemistry Letters 2013.0
Identification and Synthesis of a Novel Selective Partial PPARδ Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo
Journal of Medicinal Chemistry 2007.0
Synthesis and Biological and Structural Characterization of the Dual-Acting Peroxisome Proliferator-Activated Receptor α/γ Agonist Ragaglitazar
Journal of Medicinal Chemistry 2003.0